URGN- Urogen Pharma Ltd.

Name: Urogen Pharma Ltd. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. URGN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Barrett Elizabeth A.	153.2K	$5.36M	-
Other	Smith Jason Drew	55.6K	$1.95M	-
Dir	Belldegrun Arie	20.0K	$699.8K	-
CFO	Degnan Chris	2.3K	$79.8K	-
Dir	Robinson James A. Jr.	2.0K	$70.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jul 27, 2020	Pfreundschuh Peter P.82	Chief Financial Officer	Sale+OE	141	$23.51	$3,314.91	-1.9%
Jul 27, 2020	Schoenberg Mark60	Chief Medical Officer	Sale+OE	70	$23.51	$1,645.70	-0.4%
Jun 4, 2020	Schoenberg Mark60	Chief Medical Officer	Sale+OE	349	$27.51	$9,601.97	-1.9%
May 20, 2020	Pfreundschuh Peter P.82	Chief Financial Officer	Sale+OE	358	$25.07	$8,975.06	-4.8%
Apr 27, 2020	Schoenberg Mark60	Chief Medical Officer	Sale+OE	70	$24.35	$1,704.50	-0.4%
Apr 27, 2020	Pfreundschuh Peter P.82	Chief Financial Officer	Sale+OE	141	$24.35	$3,433.35	-2.2%
Apr 27, 2020	Mullennix Stephen	Chief Operating Officer	Sale+OE	145	$24.35	$3,530.75	-1.4%
Feb 20, 2020	Pfreundschuh Peter P.82	Chief Financial Officer	Sale+OE	360	$29.68	$10,684.80	-5.6%
Feb 14, 2020	Mullennix Stephen	Chief Operating Officer	Sale+OE	612	$28.04	$17,160.48	-5.9%
Jan 27, 2020	Pfreundschuh Peter P.82	Chief Financial Officer	Sale+OE	667	$29.28	$19,529.76	-13.1%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC